Free US stock correlation to major indices and sector benchmarks for performance attribution analysis. We help you understand how your portfolio moves relative to broader market benchmarks.
Spyre Therapeutics (SYRE) has experienced a notable pullback in recent trading, with the stock slipping roughly 2% to $74.14. This decline brings the shares closer to their established support level near $70.43, while resistance remains around $77.85. Volume over the past several sessions has been m
Spyre Therapeutics (SYRE) Stock: Down -2.00%, Support Test at $70.43 2026-05-15 - High Volume Stocks
SYRE - Stock Analysis
4892 Comments
1813 Likes
1
Zack
Trusted Reader
2 hours ago
That’s a certified wow moment. ✅
👍 43
Reply
2
Wister
Returning User
5 hours ago
I read this and now I’m confused with purpose.
👍 42
Reply
3
Jaidence
Engaged Reader
1 day ago
Market is testing resistance levels; a breakout could signal further gains.
👍 114
Reply
4
Deztini
Elite Member
1 day ago
Traders are watching for confirmation above key resistance points.
👍 104
Reply
5
Kendrix
Engaged Reader
2 days ago
Well-structured breakdown, easy to follow and understand the current trends.
👍 202
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.